Ringer Acetate Based Modified Del Nido Cardioplegia Solution Versus HTK Solution Cardioplegia Solution in Cardiac Surgery

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 124 participants.

Also called NCT06414330

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 124 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06414330
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Egypt (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06414330. Randomized; no masking; primary purpose prevention. Start 2024-06-01 (actual); primary completion 2025-11-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Ringer Acetate Based Modified Del Nido Cardioplegia Solution Versus HTK Solution Cardioplegia Solution in Cardiac Surgery
Acronym
HTK
Condition
Cardiac Ischemia
Intervention (Biological)
Ringer acetate based Del Nido cardioplegia
Intervention (Biological)
HTK
Lead sponsor
Assiut University (class: other)
Collaborator
Ahmed Ismail Abdelsabour (class: not stated)
Collaborator
Ramy Mustafa Abdelgawad Mohamed (class: not stated)
Collaborator
Ibrahim Mohamed Imbaby (class: not stated)
Collaborator
Amr Ibrahim Abdelaal (class: not stated)
Collaborator
Mahmoud Mohamed Atef Sallam (class: not stated)
Collaborator
Mohamed, Ahmed Abdelhay Mohamed (class: not stated)

Record details

Record id
cardio:ct-nct06414330
Content hash
7d2c6cc70464fc2f4e106cf74cc1344f60a0243bb81cfb147dcebbdf742ebf85